Proteasome inhibitors
Carfilzomib
The FDA lists this product in 11 strengths and forms.
Composition
- Active ingredients
- CARFILZOMIB 60MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CARFILZOMIB 60MG/VIAL · PowderThis page
- CARFILZOMIB 60MG/VIAL · PowderANDA209425-001 · Discontinued
- CARFILZOMIB 30MG · InjectableANDA209526-002 · Tentative approval
- CARFILZOMIB 60MG · InjectableANDA209526-003 · Tentative approval
- CARFILZOMIB 10MG · InjectableANDA209526-001 · Tentative approval
- CARFILZOMIB 30MG/VIAL · PowderANDA211185-001 · Discontinued
- CARFILZOMIB 60MG/VIAL · PowderANDA209330-002 · Discontinued
- CARFILZOMIB 10MG/VIAL · PowderANDA209330-001 · Discontinued
- CARFILZOMIB 60MG/1VIAL · PowderANDA219276-001 · Tentative approval
- CARFILZOMIB 60MG/VIAL · PowderANDA209422-001 · Prescription
- CARFILZOMIB 60MG/VIAL · PowderANDA209528-001 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA210823.
At a glance
- Brand name
- Carfilzomib
- Drug class
- Proteasome inhibitors
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Eugia Pharma
- Status
- Tentative approval
- FDA approval
- 25 Nov 2022
- Application
- ANDA210823-001
- RxCUI
- 1302966